Mangalam Drugs & Organics

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue57.3549.5758.6067.3857.23
Expenses70.3462.0468.4380.6563.98
EBITDA-4.47-2.81-1.32-5.531.02
Operating Profit-8.96-7.44-5.79-10.19-3.07
Profit Before Tax-13.00-12.47-9.84-13.27-6.75
Net Profit-13.80-7.35-9.84-13.42-7.64
Financial Ratios
Operating Profit Margin-7.83%-5.70%-2.26%-8.22%1.77%
Net Profit Margin-24.12%-14.92%-16.86%-19.94%-13.38%
Earning Per Share (Diluted)-8.72-4.64-6.21-8.48-4.83
Dividends Per Share0.000.000.000.000.00